Sveriges Riksbank
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
| Bid procedure, 2025-04-11 | |
| Bonds | SWEDEN I/L BOND: 3113. SE0009548704. 2027-12-01 SWEDEN I/L BOND: 3114, SE0013748258, 2030-06-01 SWEDEN I/L BOND: 3115, SE0016786560, 2039-06-01 |
| Bid date | 2025-04-11 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Offered volume (corresponding nominal amount) | 3113: 400 million SEK +/-400 million SEK 3114: 300 million SEK +/-300 million SEK 3115: 100 million SEK +/-100 million SEK |
| Highest permitted bid volume (corresponding nominal amount) | 3113: 400 million SEK per bid 3114: 300 million SEK per bid 3115: 100 million SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 10 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2025-04-15 |
| Settlement amount | To be paid to the Riksbank's account in Euroclear Sweden AB's securities settlement system SWIFT: VPCSSESSXXX Account: 1 4948 6383 CTM BIC: RIKSSESS ALERT acronym: RIKSBANK |
Stockholm, 2025-04-04
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
EVS Broadcast Equipment18.4.2025 18:30:00 CEST | Press release
EVS Broadcast Equipment reports update of share buyback program
AMG Critical Materials N.V.18.4.2025 18:00:00 CEST | Press release
AMG Signs Exclusive Agreement with Grupo Lagoa
Syensqo SA18.4.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
Ageas18.4.2025 17:40:00 CEST | Press release
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
Sanofi Winthrop Industrie18.4.2025 17:15:00 CEST | Press release
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom